PMEL and neoplasm: In order to study the consequence of the use of the vaccine-induced immunologic answer for the progression of viral-associated HNSCC, single (gp100) and multiple (B16-tumor lysate containing gp100) immunogenic viral antigens were closed within lactic-co-glycolic acid (PLGA) nanoparticles.